Hyperfine, Inc. to Participate in Upcoming Investor Conferences

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced their schedule for upcoming investor conferences.

Hyperfine will discuss with investors recently announced milestones and growth catalysts, including its two major new technology clearances, commercial launch and market feedback for the next generation Swoop® system powered by Optive AI™ software, commercial launch for its new office business, growth plans in the hospital setting, and updates on its clinical evidence initiatives across the hospital and office verticals.

UPCOMING CONFERENCES

H.C. Wainwright 27th Annual Global Investment Conference - September 8-10, 2025. All in-person presentations and meetings will be held at the Lotte New York Palace Hotel in New York City. Hyperfine’s management is scheduled to present on Monday, September 8, 2025 at 12:00 pm ET. 1x1 meetings will be conducted on Monday, September 8. For conference registration or inquiries, contact [e-mail].

Lake Street Capital Markets 9th Annual Best Ideas Growth Conference Big 9 - Thursday, September 11, 2025, at The Yale Club in New York City. All 1x1 meetings will be conducted on Thursday, September 11th. For conference registration or inquiries, contact [e-mail].

A live webcast of the H.C. Wainwright event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: investors.hyperfine.io. The webcast will be archived and available for replay for at least 90 days after the event.

About Hyperfine, Inc. and the Swoop® Portable MR Imaging® Systems
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first U.S. Food and Drug Administration (FDA)-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visit hyperfine.io.

The Swoop® Portable MR Imaging® systems are FDA cleared for brain imaging of patients of all ages. They are portable, ultra-low-field magnetic resonance imaging devices for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. The Swoop® system also has CE Mark in the European Union and UKCA Mark in the United Kingdom. The Swoop® system is commercially available in a select number of international markets.

Hyperfine, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc.